EIF2B4 and neoplasm: Knockdown of eIF2Bδ did reduce the viability of tumor-derived organoids, but also of murine WT organoids (Appendix Fig. S9C–H), suggesting that modulation of eIF2Bδ has rather unspecific, toxic cellular effects.